How many years can you live taking ibrutinib?

Taking ibrutinib (Ibrutinib) can prolong the survival of patients with leukemia and lymphoma, but the specific extent of life extension varies between individuals and the type of disease. Ibrutinib is a targeted therapy drug used to treat specific types of leukemia and lymphoma, such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mucosa-associated lymphoid tissue lymphoma (MALT lymphoma), etc.

Clinical research and clinical practice have proven that ibrutinib can significantly prolong the survival of some patients. Ibrutinib often provides an effective treatment option that improves disease outcomes for patients who have previously failed to achieve adequate response to other treatments. However, it is important to emphasize that the specific life-extending effects vary depending on the patient's condition, response to treatment, age, overall health, and other factors.

Importantly, ibrutinib is typically used as a maintenance treatment to control the disease and improve the patient's quality of life, rather than to cure the disease. Therefore, even if ibrutinib prolongs a patient's survival, the patient still needs to continue receiving treatment until the doctor decides to stop or the patient can no longer tolerate the drug.

Ibrutinib is currently on the market in China and is included in medical insurance. The domestic price ranges from 10,000 to 20,000. Due to different medical insurance policies in different places, the price is also different. For specific reimbursement information, please consult the local hospital pharmacy or medical insurance bureau. The cheaper types of ibrutinib abroad are generic drugs, mainly Indian generic drugs, Bangladeshi generic drugs and Laos generic drugs, with prices ranging from a few hundred to several thousand yuan. And the ingredients of generic ibrutinib drugs are basically the same as those of domestic ibrutinib drugs.